Burden of adult atopic dermatitis and unmet needs with existing therapies

References

• Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl. 1):1–11.
   Google Scholar
• Harrop J, Chinn S, Verlato G, et al. Eczema, atopy and allergen exposure in adults: a population-based study. Clin Exp Allergy. 2007;37(4):526–535.
   PubMed Web of Science ®Google Scholar
• Sacotte R, Silverberg JI. Epidemiology of adult atopic dermatitis. Clin Dermatol. 2018;36(5):595–605.
   PubMed Web of Science ®Google Scholar
• Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. Atopic dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population. J Invest Dermatol. 2019;139(3):583–590.
   PubMed Web of Science ®Google Scholar
• US Census Bureau. S0101 age and sex 2020. ACS 5-year estimates subject tables; 2020. Available from: https://data.census.gov/cedsci/table?y=2020&tid=ACSST5Y2020.S0101
   Google Scholar
• Bieber T, Straeter B. Off-label prescriptions for atopic dermatitis in Europe. Allergy. 2015;70(1):6–11.
   PubMed Web of Science ®Google Scholar
• Laughter MR, Maymone MBC, Mashayekhi S, et al. The global burden of atopic dermatitis: lessons from the global burden of disease study 1990–2017. Br J Dermatol. 2021;184(2):304–309.
   PubMed Web of Science ®Google Scholar
• Drucker AM, Wang AR, Li WQ, et al. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26–30.
   PubMed Web of Science ®Google Scholar
• Silverberg JI, Gelfand JM, Margolis DJ, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340–347.
   PubMed Web of Science ®Google Scholar
• Silverberg JI, Gelfand JM, Margolis DJ, et al. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults. Br J Dermatol. 2019;181(3):554–565.
   PubMed Web of Science ®Google Scholar
• Eckert L, Gupta S, Amand C, et al. Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: an analysis using the National Health and Wellness Survey. J Am Acad Dermatol. 2017;77(2):274–279.e3.
   PubMed Web of Science ®Google Scholar
• Smith Begolka W, Chovatiya R, Thibau IJ, et al. Financial burden of atopic dermatitis out-of-pocket health care expenses in the United States. Dermatitis. 2021;32(1S):S62–S70.
   PubMed Web of Science ®Google Scholar
• Eckert L, Gupta S, Amand C, et al. The burden of atopic dermatitis in US adults: health care resource utilization data from the 2013 National Health and Wellness Survey. J Am Acad Dermatol. 2018;78(1):54–61.e1.
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–132.
   PubMed Web of Science ®Google Scholar
• Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–349.
   PubMed Web of Science ®Google Scholar
• Simpson EL, Bruin-Weller M, Flohr C, et al. When does atopic dermatitis warrant systemic therapy? Recommendations from an Expert Panel of the International Eczema Council. J Am Acad Dermatol. 2017;77(4):623–633.
   PubMed Web of Science ®Google Scholar
• FDA Approved Drugs. Listings in atopic dermatitis. Falls Church (VA): CenterWatch; 2022 [cited 2022 May 6]. Available from: https://www.centerwatch.com/directories/1067-fda-approved-drugs/topic/760-atopic-dermatitis
   Google Scholar
• Bieber T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov. 2022;21(1):21–40.
   PubMed Web of Science ®Google Scholar
• Wei W, Ghorayeb E, Andria M, et al. A real-world study evaluating adeQUacy of existing systemic treatments for patients with moderate-to-severe atopic dermatitis (QUEST-AD): baseline treatment patterns and unmet needs assessment. Ann Allergy Asthma Immunol. 2019;123(4):381–388.e2.
   PubMed Web of Science ®Google Scholar
• Anderson P, Austin J, Lofland JH, et al. Inadequate disease control, treatment dissatisfaction, and quality-of-life impairments among US patients receiving topical therapy for atopic dermatitis. Dermatol Ther. 2021;11(5):1571–1585.
   Web of Science ®Google Scholar
• Bacci E, Rentz A, Correll J, et al. Patient-reported disease burden and unmet therapeutic needs in atopic dermatitis. J Drugs Dermatol. 2021;20(11):1222–1230.
   PubMed Web of Science ®Google Scholar
• Silverberg JI, Gelfand JM, Margolis DJ, et al. Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis. Ann Allergy Asthma Immunol. 2018;121(4):464–468.e3.
   PubMed Web of Science ®Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216.
   PubMed Web of Science ®Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365.
   PubMed Web of Science ®Google Scholar
• Atkinson MJ, Kumar R, Cappelleri JC, et al. Hierarchical construct validity of the Treatment Satisfaction Questionnaire for Medication (TSQM version II) among outpatient pharmacy consumers. Value Health. 2005;8(Suppl. 1):S9–S24.
   PubMed Web of Science ®Google Scholar
• Whiteley J, Emir B, Seitzman R, et al. The burden of atopic dermatitis in US adults: results from the 2013 National Health and Wellness Survey. Curr Med Res Opin. 2016;32(10):1645–1651.
   PubMed Web of Science ®Google Scholar
• Klein PA, Clark RAF. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol. 1999;135(12):1522–1525.
   PubMedGoogle Scholar
• Dimson S, Nanayakkara C. Do oral antihistamines stop the itch of atopic dermatitis? Arch Dis Child. 2003;88(9):832–833.
   PubMed Web of Science ®Google Scholar
• Herman SM, Vender RB. Antihistamines in the treatment of atopic dermatitis. J Cutan Med Surg. 2003;7(6):467–473.
   PubMed Web of Science ®Google Scholar
• Matterne U, Böhmer MM, Weisshaar E, et al. Oral H1 antihistamines as ‘add-on’ therapy to topical treatment for eczema. Cochrane Database Syst Rev. 2019;1(1):CD012167.
   PubMed Web of Science ®Google Scholar
• Rukwied R, Lischetzki G, McGlone F, et al. Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. Br J Dermatol. 2000;142(6):1114–1120.
   PubMed Web of Science ®Google Scholar
• Nakahara T, Fujita H, Arima K, et al. Treatment satisfaction in atopic dermatitis relates to patient-reported severity: a cross-sectional study. Allergy. 2019;74(6):1179–1181.
   PubMed Web of Science ®Google Scholar
• Chovatiya R, Paller AS. JAK inhibitors in the treatment of atopic dermatitis. J Allergy Clin Immunol. 2021;148(4):927–940.
   PubMed Web of Science ®Google Scholar
• Pino Lopez J, Kromer C, Herr R, et al. Drug survival rates and reasons for drug discontinuation in patients with atopic dermatitis: a retrospective study of adult outpatients. Eur J Dermatol. 2021;31(2):233–238.
   PubMed Web of Science ®Google Scholar
• Augustin M, Langenbruch A, Blome C, et al. Characterizing treatment-related patient needs in atopic eczema: insights for personalized goal orientation. J Eur Acad Dermatol Venereol. 2020;34(1):142–152.
   PubMed Web of Science ®Google Scholar
• Understanding the Lived Experience of Eczema. The “Voice of the Patient” report on the eczema patient-focused drug development meeting. More Than Skin Deep; 2020.
   Google Scholar
• Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. J Multidiscip Healthc. 2016;9:211–217.
   PubMed Web of Science ®Google Scholar